Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gsk Plc ADR
(NY:
GSK
)
44.15
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gsk Plc ADR
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
28
29
Next >
The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict
March 30, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Omicron BA.2 Variant Represents More Than 50% COVID-19 Cases, Says CDC Estimates: WSJ
March 30, 2022
According to the Centers for Disease Control and Prevention estimates, the omicron BA.2 variant represents approximately 55% of new COVID-19 cases in the U.S., as signs suggest infections are edging...
Via
Benzinga
FDA Approves ViiV Healthcare's Cabenuva For Virologically Suppressed Adolescents With HIV
March 29, 2022
Via
Benzinga
Biden Administration Proposes $82B In Spending For Future Pandemics Preparedness
March 29, 2022
President Biden's budget proposal calls for $81.7 billion to spend over five years preparing for future pandemics, which would be a significant investment in boosting the country
Via
Benzinga
LifeMine Therapeutics, GSK Ink $70M Drug Discovery, Development Pact
March 23, 2022
Via
Benzinga
Monday Markets News
March 28, 2022
Japanese Takeda TAK shares failed to thrive after its edema prevention drug was approved.
Via
Talk Markets
FDA Says Current Dose Of GSK-Vir's COVID-19 Therapy Unlikely To Work Against Omicron Subvariant
March 28, 2022
Via
Benzinga
Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs
March 28, 2022
As these Chinese stocks face delisting, some may provide a contrarian play on improving relations between the U.S. and China.
Via
InvestorPlace
Drug makers, Scientists Working For Long COVID Treatments: Reuters
March 25, 2022
Researchers and drugmakers, including those who have launched antiviral pills and monoclonal antibodies for COVID-19, are having early discussions about targeting Long COVID,
Via
Benzinga
How Rivals Merck, Bristol Myers Benefit From Eli Lilly's FDA Snag
March 24, 2022
The Food and Drug Administration on Thursday rejected a lung cancer drug Eli Lilly tested only in China, but LLY stock inched higher.
Via
Investor's Business Daily
Why Most Kids Did Not Suffer Badly Due To COVID-19 Infection? Scientists Look To Solve Mystery: CNBC
March 24, 2022
The COVID-19 pandemic has led to over 6 million fatalities. The scientists are still studying why most children do not suffer badly from coronavirus infection.
Via
Benzinga
Ahead Of Moderna's Midstage mRNA Flu Vaccine Readout, Analyst Says Drugmaker Likely To Be First To Market
March 21, 2022
After COVID-19 vaccine-induced strength, Moderna, Inc. (NASDAQ: MRNA) is on the lookout for the next big catalyst to boost its rangebound stock. The Moderna Analyst: BofA...
Via
Benzinga
Health Experts Forecast Increase In COVID-19 Cases In US Amid New Omicron Subvariant: CNBC
March 21, 2022
U.S. health experts warn that an emerging, highly contagious COVID-19 omicron variant, BA.2, could soon increase domestic coronavirus cases.
Via
Benzinga
WHO Foundation Warns Global Economy To Lose "Trillions Of Dollars" On COVID-19 Vaccine Inequality: CNBC
March 16, 2022
The WHO Foundation CEO, Anil Soni, has told CNBC that the global economy will lose “trillions of dollars” if more COVID-19 vaccines aren&
Via
Benzinga
News-Filled Day
March 15, 2022
The price of oil fell to below $100/oz on the prospect of lower demand from the PRC.
Via
Talk Markets
Ideaya Biosciences' IDE397 Shows Preliminary Tolerability In Early-Stage Solid Tumor Trial
March 15, 2022
IDEAYA Biosciences Inc (NASDAQ: IDYA) has announced
Via
Benzinga
GSK/Vir Biotech's COVID-19 Antibody Associated With Resistance Mutations, New Research Shows
March 11, 2022
According to new research in Australia, some people have developed sotrovimab-resistant mutations following infusions with the GlaxoSmithKline Plc (NYSE: GSK...
Via
Benzinga
7 Drug Stocks to Consider After the Viatris Plunge
March 10, 2022
As Viatris and other generic drug makers plunge, what should you buy instead? Consider these seven well-known drug stocks, all of which are good value in what's still a pricey market.
Via
InvestorPlace
Pharmaceutical Companies Are Reportedly Refocusing On Mysterious Rise In Shingles Infections As COVID Declines
March 07, 2022
Photo Credit: Photo by CDC & Klara Kulikova This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be...
Via
Benzinga
36 Stocks To Watch After Biden's First State of The Union Address
March 02, 2022
President Joe Biden hosted his first State of the Union Address Tuesday in front of members of Congress. In the speech, Biden discussed several items that he has already helped...
Via
Benzinga
Putin on the brink
February 28, 2022
For the first time in history, Swiss banks have penalized account owners for political actions and joined a SWIFT boycott.
Via
Talk Markets
GSK Stops Additional Three Respiratory Virus Vaccine Trials In Pregnant Women
February 28, 2022
GlaxoSmithKline Plc (NYSE: GSK) has halted enrollment and vaccination in three trials of its experimental vaccine against the respiratory syncytial virus (RSV) in...
Via
Benzinga
Does the FDA Rollback Of Regeneron And Eli Lilly COVID Treatment EUAs Signal A Need To Look Beyond Monoclonal Antibodies? NanoViricides, Inc. Looks To Meet This Need With A New Approach
February 28, 2022
Photo credit: Marcelo Leal and Kate Hliznitsova on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended...
Via
Benzinga
Does CBD Have To Be Water Soluble? One Group Of Scientists Say Yes For Better Absorption
February 25, 2022
Several former scientists and staff from companies like Johnson & Johnson (NYSE:
Via
Benzinga
AstraZeneca, GSK's COVID-19 Therapies Lose Efficacy Against Omicron's Subvariants
February 25, 2022
The FDA authorized an increased dose in the case of AstraZeneca Plc's (NASDAQ: AZN) pre-exposure prophylaxis drug Evusheld (tixagevimab and cilgavimab)....
Via
Benzinga
Canada Approves First Plant-Based COVID-19 Vaccine
February 25, 2022
As Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline Plc's (NYSE: GSK) COVID-19 vaccine finally heads to regulators, another shot using GSK's pandemic...
Via
Benzinga
Red Ink
February 24, 2022
There is little joy in stocks today as even companies reporting good results are being hit by fear of Ukraine sanctions.tbph
Via
Talk Markets
A Receding tide
February 23, 2022
Sanofi and GlaxoSmithKline have developed a new Covid-19 vaccine which they claim is 100% efficient.
Via
Talk Markets
Sanofi-GSK Prepare Regulatory Filings For COVID-19 Vaccine After Booster Data
February 23, 2022
Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline plc (NYSE: GSK) are seeking regulatory approval for their COVID-19 vaccine to be used as a booster, as well as...
Via
Benzinga
Holiday Over
February 22, 2022
China is busily avoiding taking sides between Ukraine and Russia.
Via
Talk Markets
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.